Early Morning Crew
    5:00 a.m. - 10:00 a.m.
  • Listen Live

  • Home
  • On The Air
    • Early Morning Crew
    • Victoria
  • Contests
    • Contest Rules
  • Employment
  • Contact Us
×
  • Facebook

  • Twitter

  • Instagram

Avril Lavigne Announces Virtual Lyme Disease Benefit Concert

Avril Lavigne has announced a one-night only livestream concert to raise funds to fight against Lyme disease.

The livestream benefit concert presented by Global Lyme Alliance is scheduled for October 24 at 5 p.m. PT. All proceeds from the concert will be donated to The Avril Lavigne Foundation and the Global Lyme Alliance.

The Grammy nominee is expected to perform songs from throughout her career, including songs off her 2019 album, Head Above Water.

“I’m so excited for fans and friends from all over the world to join me and my very special guests for #FightLyme, which will benefit the Lyme community,” Lavigne said in a statement. “It’s going to be an evening to remember full of hope, great music and exciting surprises!”

In 2015, Lavigne revealed that she had been diagnosed with Lyme disease after contracting the disease from a tick bite the previous spring. She was “bedridden for five months.”

Tickets for the show are available for purchase at www.avrillavigne.com.

Share

Recent News

Peter Gabriel Announces Additional North American Shows

Daryl Hall To Support Billy Joel At BST Hyde Park

Chlöe Bailey Reveals ‘In Pieces’ Tracklist Featuring Chris Brown, Future, & Missy Elliott

Kendrick Lamar, Billie Eilish & Red Hot Chili Peppers Among Lollapalooza 2023 Headliners

Matchbox Twenty Return With New Single ‘Wild Dogs (Running In A Slow Dream)’

Taylor Swift’s ‘Anti-Hero’ Reaches No. 1 On Billboard’s Adult Contemporary Chart

YES Postpone 2023 Relayer European, U.K. Tour

BTS’ Jimin Shares New Solo Single ‘Set Me Free Pt.2’

Usher Shares First New Single In Three Years ‘GLU’

Patti Smith Covers ‘She’s Leaving Home’ At Paul McCartney Tribute Concert

  • EEO Reports
  • FCC Public File
  • Careers
  • Privacy Policy
  • Terms of Use
Copyright© 2023 WAHR. All rights reserved. Internet development by